Tandem Diabetes Care | Le Bénéfice D'Exploitation



Operating Profit Changement Date
Abbott USD 1.66B 253M 2025-03
Align Technology USD 131.1M 13.05M 2025-03
AtriCure USD -5954000 8.57M 2025-03
Baxter International USD -435000000 590M 2024-12
Becton, Dickinson and Co. USD 546M 93M 2025-03
Boston Scientific USD 921M 246M 2025-03
Cooper Companies USD 182M 16.4M 2025-01
Dexcom USD 133.7M 55.2M 2025-03
Edwards Lifesciences USD 394.8M 82.2M 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Globus Medical USD 97M 36.73M 2025-03
ICU Medical USD 37.69M 29.46M 2024-12
Insulet USD 49.3M 60M 2025-03
Integra LifeSciences USD -15961000 51.19M 2025-03
Intuitive Surgical USD 578.1M 156.8M 2025-03
J&J USD 13.63B 9.74B 2025-03
Masimo USD 78M 437.1M 2025-03
Medtronic USD 1.44B 210M 2025-04
Merit Medical Systems USD 41.03M 4.47M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Stryker USD 837M 256M 2025-03
Tandem Diabetes Care USD -120878000 120.3M 2025-03
Teleflex USD 130.32M 240.71M 2025-03
Zimmer Biomet Holdings USD 389M 109.5M 2024-12



Tandem Diabetes Care Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.